Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

11
Activation 0f S- phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1 ) Active (E2F)

description

Active (E2F). Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1). Strategies for signalling inhibition. Immune effector cell. Anti-ligand mAbs. Bispecific Abs. scFv/toxin conjugates. Ligand/toxin conjugate. Ligand- genistein conjugates. Anti-receptor mAbs. - PowerPoint PPT Presentation

Transcript of Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

Page 1: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

Activation 0f S-phase genes(Cycle E, A, E2Fs,

DHFR,TK,TS,POL,CDK1)

Active (E2F)

Page 2: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Page 3: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Page 4: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Page 5: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Page 6: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Page 7: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Page 8: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

Strategies for signalling inhibition

Tyrosine kinase inhibitors (TKIs)

Immuneeffector cell

Anti-ligand mAbs

BispecificAbs

Anti-receptormAbs

Ligand/toxin conjugate

scFv/toxinconjugates

Ligand-genisteinconjugates

IntracellularscFvs

Nucleus

Antisense

Inhibitors of other signalling molecules

Page 9: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

DNA

Mode of action of EGFR inhibitors

Membrane

Extracellular

Intracellular

R

K

R

K EGFR-TKIEGFR-TKI Signalling

Proliferation Cell survival (anti-apoptosis)

Growth factors

Chemotherapy/radiotherapy sensitivity

Angiogenesis

Metastasis

R, epidermal growth factor receptor

EGF/TGFα

Antibody

Page 10: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Page 11: Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)